APA-Zitierstil (7. Ausg.)

Bahrami, E., Schmid, J. P., Jurinovic, V., Becker, M., Wirth, A., Ludwig, R., . . . Jeremias, I. (2023). Combined proteomics and CRISPR-Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo. Molecular cancer, 22, . https://doi.org/10.1186/s12943-023-01803-0

Chicago-Zitierstil (17. Ausg.)

Bahrami, Ehsan, et al. "Combined Proteomics and CRISPR-Cas9 Screens in PDX Identify ADAM10 as Essential for Leukemia in Vivo." Molecular Cancer 22 (2023). https://doi.org/10.1186/s12943-023-01803-0.

MLA-Zitierstil (9. Ausg.)

Bahrami, Ehsan, et al. "Combined Proteomics and CRISPR-Cas9 Screens in PDX Identify ADAM10 as Essential for Leukemia in Vivo." Molecular Cancer, vol. 22, 2023, https://doi.org/10.1186/s12943-023-01803-0.